Medtronic and Philips, two global leaders in healthcare technology, announced a significant step forward in their strategic collaboration in patient monitoring, signing a multi-year partnership agreement focused on improving patient care and expanding access to technology.
醫療技術領域的兩大全球領導者美敦力和飛利浦宣佈，他們在患者監護方面的戰略協作取得了重要進展，簽署了一項多年合作伙伴協議，重點關注改善患者護理並擴大技術的獲取途徑。
Medtronic and Philips have a strong history of partnership in monitoring since 1992 and continue to work together to provide combined leading technologies for individual monitoring parameters.
自 1992 年以來，美敦力和飛利浦在監護方面有着長期的合作歷史，並繼續共同努力爲個人監護參數提供組合領先的技術。
The new strategic partnership agreement includes the integration of next-generation technologies from Medtronic into Philips’ monitoring solutions, providing a streamlined offering for healthcare providers. Philips' patient monitoring systems currently incorporate world-class Medtronic technology, including Nellcor™ pulse oximetry, Microstream™ capnography, and BIS™ brain monitoring.
新的戰略合作協議包括將美敦力的下一代技術整合到飛利浦的監測解決方案中，爲醫療保健提供者提供簡化的服務。飛利浦的患者監測系統目前集成了世界級的美敦力技術，包括Nellcor™脈搏血氧飽和度監測、Microstream™二氧化碳圖和BIS™腦監測。
Under the new agreement, Philips will also bundle its essential supplies, including ECG, NIBP, and batteries, with Philips’ Medtronic-enabled monitors. This combined offering helps better meet the needs of clinicians around the globe through expanded equipment access to the latest technology and through joint training and education programs designed to improve patient care..
根據新協議，飛利浦還將把其重要耗材（包括心電圖、無創血壓和電池）與其支持美敦力的監護儀捆綁在一起。這一組合產品通過擴大對最新技術設備的使用權限，以及通過旨在改善患者護理的聯合培訓和教育項目，更好地滿足了全球臨牀醫生的需求。
Reinforcing their dedication to high-quality, safe monitoring, the two companies are also establishing a pledge program. Both organizations believe using products that have been rigorously validated and tested on both parties' equipment is essential for ensuring patient safety.
兩家公司還建立了宣誓計劃，以加強他們對高質量、安全監測的承諾。這兩個組織都認爲，使用在雙方設備上經過嚴格驗證和測試的產品，對確保患者安全至關重要。
“We’re proud to strengthen our collaboration with Medtronic, a partner that shares our commitment to expanding access to safe, reliable patient care,” said Sachin Chaudhari, vice president and general manager, Clinical Applications and Devices, Philips Hospital Patient Monitoring. “By providing a comprehensive monitoring solution that is validated throughout all stages, we’re supporting clinicians’ heavy workloads and complex patient cases by providing tools that can help address the daily challenges care teams face.”.
“我們很高興加強與美敦力的合作，這是一個與我們一樣致力於擴大安全、可靠的患者護理渠道的合作伙伴，”飛利浦醫院患者監護部門臨牀應用和設備副總裁兼總經理薩欽·查哈里表示。“通過提供一個在各個階段都經過驗證的全面監測解決方案，我們爲臨牀醫生繁重的工作量和複雜的患者病例提供了支持，這些工具可以幫助應對護理團隊面臨的日常挑戰。”
With a shared commitment to enhancing patient care, the continued innovation that Medtronic is delivering — coupled with Philips’ market-leading monitoring solutions — will provide clinicians, patients, and caregivers greater insights and reliable monitoring.
通過共同致力於提升患者護理，美敦力持續帶來的創新與飛利浦市場領先的監測解決方案相結合，將爲臨牀醫生、患者和護理人員提供更深入的洞察和可靠的監測。
“Together with Philips, we are eager to continue to integrate next-generation technologies and leverage our combined global presence to empower healthcare professionals with world-class technology to personalize patient care, anytime, anywhere,” said Brian Blomerth, vice president of strategy operations and chief financial officer for the Acute Care & Monitoring business, which is part of the Medical Surgical Portfolio at Medtronic.
“我們與飛利浦一起，渴望繼續整合下一代技術，利用我們共同的全球影響力，爲醫療專業人員提供世界級的技術，以隨時隨地個性化患者護理。”美敦力外科手術產品組合中急性護理和監測業務的戰略運營副總裁兼首席財務官布萊恩·布洛梅斯說道。
“The patient monitoring technology from Philips already incorporates the market-leading Medtronic brands of Nellcor™ pulse oximetry, Microstream™ capnography, and BIS™ brain monitoring, and building on this foundation exemplifies our dedication to advancing innovation and enhancing patient care.”.
“飛利浦的患者監測技術已經融合了市場領先的美敦力旗下Nellcor™脈搏血氧儀、Microstream™呼氣末二氧化碳監測和BIS™腦部監測品牌，而在此基礎上進一步發展則體現了我們對推動創新和提升患者護理的承諾。”
About Philips
關於飛利浦
Royal Philips is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home..
皇家飛利浦是一家領先的健康技術公司，致力於通過有意義的創新來改善人們的健康和福祉。飛利浦以患者和人民爲中心的創新利用先進技術，並結合深入的臨牀和消費者洞察，爲消費者提供個人健康解決方案，爲醫療機構及其患者提供專業的健康解決方案，涵蓋醫院和家庭場景。
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. In 2023, Philips generated sales of EUR 18.2 billion and employs approximately 69,100 employees with sales and services in more than 100 countries.
總部位於荷蘭的飛利浦是診斷影像、超聲、影像引導治療、患者監護和企業信息化以及個人健康領域的領導者。2023年，飛利浦的銷售額達到182億歐元，在全球100多個國家擁有約69,100名員工，負責銷售和服務。
News about Philips can be found at .
有關飛利浦的新聞可以在找到。
www.philips.com/newscenter
www.philips.com/newscenter
.
。
About Medtronic
美敦力公司簡介
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries.
大膽思考。更果敢的行動。我們是美敦力。美敦力公司總部位於愛爾蘭戈爾韋，是全球領先的醫療技術公司，通過尋找和發現解決方案，勇敢地應對人類面臨的最嚴峻的健康問題。我們的使命——減輕病痛、恢復健康、延長生命——將遍佈150多個國家的95,000多名充滿熱情的員工團結在一起。
Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day.
我們的技術和療法治療70種健康狀況，包括心臟設備、手術機器人、胰島素泵、手術工具、患者監測系統等。憑藉我們廣泛的知識、永無止境的好奇心和幫助所有需要幫助的人的願望，我們提供創新技術，每秒、每小時、每一天都在改變兩個人的生活。
Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit .
隨着我們推動以洞察力爲導向的護理、以人爲本的體驗以及爲我們的世界帶來更好的結果，期待我們做得更多。在我們所做的一切中，我們正在創造非凡。欲瞭解有關美敦力的更多信息，請訪問。
medtronic.com
美敦力官網
and follow Medtronic on
並關注美敦力
領英
.
。
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
任何前瞻性陳述都受到風險和不確定性的影響，例如美敦力公司向證券交易委員會提交的定期報告中描述的那些。實際結果可能與預期結果有重大差異。
Contacts:
聯繫人：
Pamela Lee
帕梅拉·李
Communications
通訊
+1-303-218-8264
+1-303-218-8264
Ryan Weispfenning
瑞安·魏斯芬寧
Investor Relations
投資者關係
+1-763-505-4626
+1-763-505-4626